Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210031423 210013498 1.69 69 Disease modification (D) 2017-01-15 2017-02-05 Inotuzumab Ozogamicin 2 N 210041053 IDELALISIB
210031424 210013506 0 58.6 Curative (C) 2016-07-24 2016-07-24 IDELALISIB 2 N 210041101 CHLORAMBUCIL + OFATUMUMAB
210031425 210013508 1.74 13.7 Disease modification (D) 2017-06-14 2017-07-25 UKALL XII Induction Phase 1 N N 210041106 RIALTO TRIAL
210031426 210013511 0 14.4 Adjuvant (A) 2016-03-02 2016-04-21 Bevacizumab 15mg/kg N N 210041115 IDELALISIB
210031427 210013512 1.7 96.1 Disease modification (D) 2015-03-04 2015-03-14 CNS GCT II Germinoma - Carbo Etop N N 210041122 PONATINIB
210031428 210022464 0 84.8 Palliative (P) 2012-11-29 2013-07-16 Dasatinib N N 210041181 DASATINIB
210031429 210013518 null null Palliative (P) 2014-12-04 2017-08-26 IDELALISIB N N 210041191 METHOTREXATE HIGH DOSE
210031430 210013521 1.75 25.5 Curative (C) null 2017-12-21 Dasatinib Y N 210041193 DASATINIB
210031431 210013526 1.73 85.2 Curative (C) 2018-08-22 2018-08-22 CHOP 02 N 210041199 METHOTREXATE HIGH DOSE
210031432 210013531 1.77 105 Curative (C) null 2013-12-11 Cyclophosphamide + Vincristine N N 210041244 PENTOSTATIN
210031434 210013534 1.68 11.5 Palliative (P) 2016-11-25 2017-04-08 LOMUSTINE + PROCARBAZINE N N 210041263 LOMUSTINE + PROCARBAZINE
210031435 210013539 null 95 null 2016-03-06 2016-03-13 RIALTO TRIAL N N 210041279 RIALTO TRIAL
210031436 210013546 1.52 61.1 Disease modification (D) 2015-09-11 2015-09-17 CNS LGG 2004 03 vinc weekly+ carbo N N 210041346 CARBOPLATIN + VINCRISTINE
210031437 210022475 1.67 69 Curative (C) 2016-04-16 2016-06-01 Cyclophosphamide + Vincristine N N 210041357 RIALTO TRIAL
210031438 210013557 null 83.9 Curative (C) 2018-01-18 2018-09-17 Erwinase (Erwinia Asparaginase) N N 210041403 BENDAMUSTINE
210031439 210013560 1.7 79.6 Disease modification (D) 2017-03-11 2017-10-19 Inotuzumab Ozogamicin N N 210041408 NELARABINE
210031440 210013561 1.77 null Curative (C) 2014-06-11 2014-06-11 CLADRIBINE N null 210041423 CLADRIBINE
210031441 210028097 null 32.9 Curative (C) 2016-05-01 2016-05-09 CVP R N N 210041452 PONATINIB
210031442 210013566 null null null 2015-09-07 2015-11-07 CNS Low Grade Glioma Vinblastine N N 210041459 VINBLASTINE
210031443 210022485 0 63.6 Curative (C) null 2015-01-10 Vinblastine weekly N N 210041488 VINBLASTINE
210031444 210013577 1.8 72.8 Curative (C) 2014-07-01 2014-07-04 Procarbazine 02 N 210041526 PROCARBAZINE
210031445 210013579 1.51 55 Palliative (P) 2019-06-03 2019-06-03 LOMUSTINE + PROCARBAZINE 02 N 210041546 LOMUSTINE + PROCARBAZINE
210031446 210013587 1.51 55 Curative (C) 2014-12-31 2014-12-31 CHLORAMBUCIL + OFATUMUMAB 02 null 210041577 INOTUZUMAB OZOGAMICIN
210031447 210038806 1.54 63 Palliative (P) null 2018-02-27 Docetaxel 75mg/m2 (21 day) N N 210041599 BEVACIZUMAB + IRINOTECAN
210031448 210037863 1.77 83.7 Palliative (P) 2013-11-04 2013-11-04 BOSUTINIB N N 210041615 CYCLOPHOSPHAMIDE HIGH DOSE
210031449 210013589 1.69 null Adjuvant (A) null 2016-09-21 PNET 4 HIT-SIOP Maintenance N Y 210041618 CISPLATIN
210031450 210013592 1.76 98.2 Palliative (P) 2019-03-10 2019-07-25 Brentuximab 2 N 210041621 IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE
210031451 210013596 0 53 Adjuvant (A) null 2015-06-05 Hydroxycarbamide 02 N 210041630 CISPLATIN
210031452 210033677 1.63 35.5 Curative (C) 2018-04-26 2018-04-28 Lenalidomide 25mg (Cycle 1 to 25) N null 210041643 CARBOPLATIN + ETOPOSIDE + VINCRISTINE
210031453 210013605 1.67 98.8 Adjuvant (A) null 2017-03-18 PENTOSTATIN + RITUXIMAB N N 210041679 METHOTREXATE + VINCRISTINE
210031454 210013608 0 null null 2018-07-16 2018-09-12 Erlotinib N Y 210041701 BEVACIZUMAB + TEMOZOLOMIDE
210031455 210033679 0 null Curative (C) 2018-02-11 2018-02-11 CVP N N 210041746 PACLITAXEL
210031456 210013614 1.6 null Curative (C) null 2014-01-21 BR14 TRIAL Y N 210041789 LENVATINIB
210031457 210013615 1.5 69.3 Curative (C) 2014-06-05 2014-07-24 CYTARABINE + ETOPOSIDE Y N 210041797 CODOX M
210031458 210013617 1.81 84.4 Curative (C) 2018-06-17 2018-06-24 CLARITY Trial N null 210041810 PACKER MAINTENANCE
210031459 210013621 null 80.5 Curative (C) 2019-05-15 2019-05-15 Gemcitabine + Oxaliplatin N N 210041817 TAVAREC TRIAL
210031460 210013625 null null Curative (C) null 2017-01-11 Nilotinib Y N 210041820 IRINOTECAN + TEMOZOLOMIDE
210031461 210013628 1.68 35 Curative (C) 2015-09-19 2015-10-16 Cytarabine HD + Methotrexate HD N N 210041854 ERLOTINIB
210031462 210013631 1.69 74 Curative (C) 2015-11-08 2016-02-02 Bevacizumab + Irinotecan Y N 210041861 CYCLOPHOSPHAMIDE HIGH DOSE
210031463 210022515 1.73 null Curative (C) 2015-04-16 2015-04-21 Lenalidomide 15mg (Cycle 1 to 25) N N 210041872 BEVACIZUMAB + LOMUSTINE
210031464 210013636 1.7 72.9 Curative (C) 2018-06-19 2018-06-19 Fludarabine oral Y N 210041902 DACTINOMYCIN + CYCLO + VINCRISTINE
210031465 210013641 1.92 null Curative (C) null 2015-07-17 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE N N 210041947 GEMCARBO
210031466 210013644 1.72 null Curative (C) 2017-11-01 2018-02-20 CLL210 TRIAL Y N 210041983 NILOTINIB
210031467 210013647 0 133 Curative (C) 2017-03-06 2017-03-06 Cisplatin chemoembolisation N null 210042028 CARBO + ETOPOSIDE + VINCRISTINE
210031468 210013648 1.54 78.8 Palliative (P) 2015-04-27 2015-05-02 CNS HGG HERBY Maint Temoz+Bev Y N 210042033 DOCETAXEL
210031469 210022525 1.75 null Curative (C) 2016-07-19 2016-07-25 LOMUSTINE + PROCARBAZINE + VINCRISTINE N N 210042045 TRASTUZUMAB EMTANSINE
210031470 210013652 1.08 38.1 Curative (C) 2014-05-05 2014-05-05 Docetaxel + Nintedanib null N 210042048 BEVACIZUMAB + LOMUSTINE
210031471 210022528 1.72 53 Curative (C) 2015-03-13 2015-04-26 FLAG N N 210042059 REGORAFENIB
210031472 210013656 1.62 null Curative (C) 2017-07-17 2017-07-17 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE Y N 210042061 FLAG
210031473 210013657 1.65 0 Curative (C) 2015-06-14 2015-06-14 Hydroxycarbamide N N 210042066 BRENTUXIMAB